We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
AUM
$5.2B
AUM Growth
-$91.8M
Cap. Flow
-$238M
Cap. Flow %
-4.58%
Top 10 Hldgs %
22.29%
Holding
328
New
43
Increased
93
Reduced
100
Closed
61

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$63.8M
2
DHR icon
Danaher
DHR
+$50.4M
3
AZO icon
AutoZone
AZO
+$36.8M
4
AGN
Allergan plc
AGN
+$33.9M
5
BIIB icon
Biogen
BIIB
+$33.5M

Sector Composition

Rank Sector Weight
1 Technology 25.03%
2 Healthcare 24.38%
3 Financials 20.66%
4 Communication Services 10.61%
5 Consumer Discretionary 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
26
PepsiCo
PEP
$186B
$49.4M 0.95%
529,056
ACM icon
27
Aecom
ACM
$9.07B
$49.4M 0.95%
1,492,715
+6,199
+0.4% +$205K
DOX icon
28
Amdocs
DOX
$5.53B
$48.4M 0.93%
887,451
+29,117
+3% +$1.6M
WFC icon
29
Wells Fargo
WFC
$261B
$48M 0.92%
853,265
-214,109
-20% -$11.9M
BAH icon
30
Booz Allen Hamilton
BAH
$8.7B
$43.3M 0.83%
1,716,902
+71,882
+4% +$1.95M
AMZN icon
31
Amazon
AMZN
$2.5T
$42.5M 0.82%
1,957,460
+219,460
+13% +$4.59M
WCN
32
Waste Connections
WCN
$42.8B
$42.2M 0.81%
1,343,930
CSCO icon
33
Cisco
CSCO
$450B
$40.9M 0.79%
1,489,155
-510,407
-26% -$14.6M
PNC icon
34
PNC Financial Services
PNC
$100B
$40M 0.77%
418,697
-174,891
-29% -$16.5M
HCA icon
35
HCA Healthcare
HCA
$84.8B
$39.6M 0.76%
436,000
-65,000
-13% -$5.21M
CCL icon
36
Carnival Corporation Ltd
CCL
$36.1B
$39.5M 0.76%
+800,020
New +$37.7M
SYK icon
37
Stryker
SYK
$127B
$38.5M 0.74%
+402,973
New +$38.2M
ABBV icon
38
AbbVie
ABBV
$458B
$38.4M 0.74%
572,000
+312,000
+120% +$20.4M
MRSH
39
Marsh
MRSH
$86.3B
$37.2M 0.72%
656,000
+46,000
+8% +$2.66M
LVNTA
40
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$36.9M 0.71%
938,845
+3,635
+0.4% +$153K
BIDU icon
41
Baidu
BIDU
$35.8B
$36.2M 0.7%
181,826
-6,790
-4% -$1.39M
RVNC
42
DELISTED
Revance Therapeutics, Inc.
RVNC
$36.1M 0.7%
1,130,409
+23,137
+2% +$595K
CELG
43
DELISTED
Celgene Corp
CELG
$35.5M 0.68%
307,008
+260,571
+561% +$29.8M
ZBH icon
44
Zimmer Biomet
ZBH
$17.7B
$35.5M 0.68%
335,098
+35,020
+12% +$3.87M
COO icon
45
Cooper Companies
COO
$13.7B
$35.5M 0.68%
797,400
+197,400
+33% +$8.9M
WBA
46
DELISTED
Walgreens Boots Alliance
WBA
$34.6M 0.67%
+410,000
New +$35.3M
EBAY icon
47
eBay
EBAY
$48.6B
$33.5M 0.65%
1,322,634
-846,858
-39% -$21.1M
ALXN
48
DELISTED
Alexion Pharmaceuticals
ALXN
$32.8M 0.63%
181,299
+170,245
+1,540% +$29.4M
ROP icon
49
Roper Technologies
ROP
$36.3B
$31.5M 0.61%
182,933
-45,224
-20% -$7.83M
EW icon
50
Edwards Lifesciences
EW
$47.6B
$31.3M 0.6%
1,320,000
+120,000
+10% +$2.71M

Similar funds

Polar Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Polar Capital held 328 positions worth $5.2B, down 1.7% from $5.29B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Polar Capital withdrew a net $238M in Q2 2015, closing 61 positions and reducing 100 holdings. Its most notable exit was Danaher, an estimated $50.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Polar Capital opened a new position in Stryker worth $38.5M.

  • Polar Capital's largest Q2 2015 buy was Stryker: 402,973 shares worth $38.5M.
  • Polar Capital added most to Celgene Corp in Q2 2015, an estimated $29.8M increase.
  • Polar Capital's biggest Q2 2015 reduction was Merck, cutting an estimated $63.8M.
  • Polar Capital fully exited Danaher in Q2 2015, selling an estimated $50.4M.
  • Polar Capital's ten largest holdings make up 22% of its $5.2B portfolio in Q2 2015.
  • Polar Capital opened 43 new positions and closed 61 in Q2 2015.
  • Polar Capital's portfolio value fell 1.7% quarter-over-quarter to $5.2B.

Based on Polar Capital's 13F filing for Q2 2015, filed 14 Aug 2015.